Delivering exceptional results with ease
Popular weight-loss drugs shouldn't carry suicide warnings, FDA says Read full article: Popular weight-loss drugs shouldn't carry suicide warnings, FDA says Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss drugs
How to Inject Safely Start by washing your hands thoroughly
GERD and dyspepsia are listed as adverse events in tirzepatide prescribing information
Using electronic health record data, researchers compared similar groups of people with type 2 diabetes: those who used a GLP-1 and FreeStyle Libre CGM (about 24,000 people) and those who used a GLP-1 only (about 500 people)
[103] The MAP approach has been further studied in over 40,000 patients tested with either the MAP or traditional ANA testing strategy (tANA), demonstrating patients who test MAP positive are at up to 6-fold increased odds of receiving a new SLE diagnosis and up to 3-fold increased odds of starting a new SLE medication regimen as compared to patients testing positive with the tANA approach
